Daniel Paz-Gomez

Dr. Daniel Paz-Gomez


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DPDaniel Paz-Gomez
Daniel Paz-Gomez
EVEmmanuel Villanueva-Chimal
Emmanuel Villanueva-Chimal
RNRosa E. Navarro
Rosa E. Navarro
For several years, DEAD box RNA helicase Vasa (DDX4) has been used as a bona fide germline marker in different organisms. C. elegans VBH-1 is a close homolog of the Vasa protein, which plays an important role in gametogenesis, germ cell survival and embryonic development. Here, we show that VBH-1 protects nematodes from heat shock and oxidative stress. Using the germline-defective mutant glp-4(bn2) we found that a potential somatic expression of vbh-1 might be important for stress survival. We also show that the VBH-1 paralog LAF-1 is important for stress survival, although this protein is not redundant with its counterpart. Furthermore, we observed that the mRNAs of the heat shock proteins hsp-1 and sip-1 are downregulated when vbh-1 or laf-1 are silenced. Previously, we reported that in C. elegans, VBH-1 was primarily expressed in P granules of germ cells and in the cytoplasm of all blastomeres. Here we show that during stress, VBH-1 co-localizes with CGH-1 in large aggregates in the gonad core and oocytes; however, VBH-1 aggregates do not overlap with CGH-1 foci in early embryos under the same conditions. These data demonstrate that, in addition to the previously described role for this protein in the germline, VBH-1 plays an important role during the stress response in C. elegans through the potential direct or indirect regulation of stress response mRNAs.

Verified
Journal Article
Open access
PDF file
DPDaniel Paz-Gomez
Daniel Paz-Gomez
MLManuel de Jesus Castillejos López
Manuel de Jesus Castillejos López
Yair RomeroYair Romero
Yair Romero
EFEdgar Flores-Soto
Edgar Flores-Soto
BRBianca Romero-Martinez
Bianca Romero-Martinez
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease with limited therapeutic options. This review focuses on the role of retinoids, particularly all-trans retinoic acid (atRA), and hypoxia in the pathogenesis of IPF. Despite an established understanding of genetic and environmental factors in IPF, the interplay between retinoid signaling and the response to hypoxia remains poorly explored due to its complexity. Preclinical evidence suggests that atRA could help reduce pulmonary fibrosis by modulating TGF-β signaling pathways and epithelial-to-mesenchymal transition (EMT). Additionally, we mention other diseases where a relationship between hypoxia and retinoids has been observed. We review how hypoxia, a key factor in the progression of IPF, may influence the efficacy of retinoid therapy. Combination strategies are explored to overcome hypoxia-induced treatment resistance. Finally, we address the complex role of retinoids in lung regeneration, balancing their potential benefits against the risk of exacerbating fibrotic processes. This review suggests that retinoids have potential as a treatment or adjuvant for IPF and highlights the need for further research to elucidate the precise mechanisms of retinoid action in IPF, particularly in hypoxia.

1 December 2008 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
DPDaniel Paz-Gomez
Daniel Paz-Gomez
VBVíctor Manuel Baizabal-Aguirre
Víctor Manuel Baizabal-Aguirre
JVJuan José Valdez-Alarcón
Juan José Valdez-Alarcón
MCMarcos Cajero-Juárez
Marcos Cajero-Juárez
ANAnja C. Nagel
Anja C. Nagel
ABAlejandro Bravo-Patiño
Alejandro Bravo-Patiño

Verified
Journal Article
Open access
PDF file
MMMisael Osmar Garcia Martin
Misael Osmar Garcia Martin
MLManuel de Jesus Castillejos López
Manuel de Jesus Castillejos López
HPHeriberto Prado-Garcia
Heriberto Prado-Garcia
SRSusana Romero-Garcia
Susana Romero-Garcia
JHJuan Carlos Huerta-Cruz
Juan Carlos Huerta-Cruz
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
Metformin, caffeine, and dichloroacetate (DCA) have shown antitumor effects. The hypoxic tumor microenvironment can modulate drug response. We aimed to analyze the interaction of metformin with caffeine or DCA in lung cancer cells (HCC827) under normoxia and hypoxia conditions. Cell viability was evaluated using the crystal violet assay after individual and combined drug treatment under normoxia (21% O2) and hypoxia (1% O2) conditions. Combination effects were analyzed using isobolographic analysis. The results show that under normoxia conditions, the combination of metformin with DCA (γ = 0.98 ± 0.35, p > 0.05) or caffeine (γ = 0.90 ± 0.34, p > 0.05) revealed additivity. However, in hypoxia, both combinations exhibited significant antagonism, with γ values appearing greater than one for metformin + DCA (γ = 4.20 ± 1.44, p < 0.05) and metformin + caffeine (γ = 2.88 ± 0.90, p < 0.05). Hypoxia significantly alters the pharmacological interaction of metformin with caffeine or DCA, which could limit their combined therapeutic potential in hypoxic tumors despite metformin’s activity in this environment. The importance of considering tumor oxygenation status in the design of combined therapies for lung cancer is emphasized.